Anionic), Crop Type Non-Crop-Based (Turf & Ornamentals, Crop-Based) and By Geography
According to Stratistics MRC, the Global Alopecia Market is accounted for $3.45 billion in 2021 and is expected to reach $7.27 billion by 2028 growing at a CAGR of 11.2% during the forecast period. Alopecia is medical condition that brings to hair loss and baldness conclusively. Hair loss may happen in entire body orpatches on whole from a small area. Alopecia is caused due to autoimmune disorders such as vitiligo, thyroid and others.
Growing Prevalence of Hair Loss
According to data published by the Journal of Clinical and Diagnostic Research (JCDR), around 60% of the population has hair thinning problems and pattern hair loss is the most common form of hair loss in both males and females. Moreover, around 2% of the population is at risk of developing AA in their lifetime globally, irrespective of gender. Major buyers of the market are patients suffering from alopecia and dermatological clinics. For instance, according to the National Institute for Health and Care Excellence (NICE), U.K., in 2020, the estimated prevalence of alopecia in the U.K. was 15 per 10,000 people. It is known to affect people of all ages, but it is most common in childhood and adolescence. Peak incidence was observed between the ages of 15 and 29. Before the age of 21, 50-60% of men experience their first bald patch. The growing need for effective treatment of hair loss is leading to rising demand for well-designed clinical trials in alopecia and approved treatments. There is an urgent need to address the unmet clinical needs of alopecia and this, in turn, is accelerating the discovery of new molecules and drugs to treat and prevent hair loss. The rising popularity of cosmetic procedures due to the growing focus on improving aesthetic appearance is further boosting patients' interest in new and emerging treatment modalities, and this is expected to significantly contribute to the revenue growth of the market.
Many of the patients/participants who reported using corticosteroids as a treatment for alopecia said corticosteroids were frequently ineffective and had significant side effects. With these treatments, some participants reported temporary success in slowing or stopping the rate of hair loss. However, many of the participants had little or no response to corticosteroid use. Hence, corticosteroids were deemed ‘ineffective’ and ‘not a viable treatment option’ by the participants.
Increasing Research and Development activities
The increasing number of clinical trials for the treatment of it is expected to aid in the growth of the global market over the forecast period. For instance, researchers from the University of Brazil conducted a randomized, placebo-controlled trial to assess the efficacy and safety of 0.5% minoxidil intradermal injections for the treatment of female androgenetic alopecia. The findings demonstrated that intradermal injections of minoxidil were more effective than placebo in the treatment of female androgenetic alopecia while also having a favorable safety profile.
Reimbursement remains one of the major threats in this market. Since most of the treatment modalities are considered as not medically essential and are categorized as cosmetic procedures, the treatment for hair loss is generally not covered under insurance plans. Out-of-pocket expenses for it treatment usually include prescription drug copays, frequent doctor visits, and co-insurance for procedures.
Dermatology Clinics segment is expected to be the largest during the forecast period
Modern treatment methods such as laser technology, a strong product pipeline, and heightened consumer awareness regarding the use of prescription medicines are the main factors responsible for the continued growth of the segment. Given the consulting dermatologist’s ability to provide appropriate customized medications or therapy that yield effective results, they are often considered the preferred option for the treatment of alopecia.
The Androgenetic Alopecia segment is expected to have the highest CAGR during the forecast period
It is known as male-pattern hair loss (MPHL), androgenetic alopecia is generally associated with medical conditions such as obesity, diabetes, coronary heart disease, hypertension, and prostate cancer. An increasing number of hair transplantation procedures and the growing availability of advanced oral alopecia drugs and licensed topical treatments drive the revenue growth of this segment.
Region with highest share:
The Asia Pacific is projected to hold the highest market share, due to an increase in penetration of alopecia products, rising disposable income, and rising consumer awareness. Moreover, improving the healthcare regulatory scenario in developing countries is expected to attract international players to invest and capitalize on the available market opportunities. For instance, in 2016, China regulatory authority, China Food, and Drug Administration, approved the iGrow laser system by Apira Science and became the first-ever laser-based hair growth device to be approved in China.
Region with highest CAGR:
North America is projected to have the highest CAGR, due to the presence of technologically advanced healthcare infrastructure, high disposable income, and availability of novel therapeutics options for the treatments. Accordingly, the high incidence and the equivalent high treatment rates concerning hair loss in the U.S. are high is one of the major drivers for the region. The growth is driven by high disease prevalence, rising consumer awareness, proactive government measures, and improvements in healthcare infrastructure. The presence of key players in this region is a key propeller of market growth. Moreover, increasing the adoption of laser-based therapy to treat alopecia is also increasing the treatment rate in the region.
Key players in the market:
Some of the key players profiled in the Alopecia Market include Cipla, Dr. Reddy’s Laboratories Ltd, Merck & Co., Viviscal, Regaine, Ranbaxy Laboratories Ltd, Kirkland Signature, Lexington International LLC, Vitabiotics, Alpecin - Dr. Kurt Wolff GmbH & Co, Johnson and Johnson, GlaxoSmithKline PLC, Sun Pharmaceutical Industries Ltd.
In Sep 2021: Dr. Reddy's Laboratories launched the prescription drug Minoxidil topical solution USP 2% and 5% for the treatment of female pattern hair loss (FPHL). “Minoxidil topical solution become available as a first-line treatment option for FPHL in India. While Minoxidil topical solution has been approved in India for the treatment of alopecia in men (male pattern baldness), there are presently no other drugs approved for the treatment of FPHL in India.
In February 2021: Viviscal™ launched hair therapy line of mixable powders designed to nourish hair from the inside out. Viviscal Hair Therapy provides a balance of nutrients that help address women's specific lifestyle needs and help form the foundation for healthy, gorgeous hair.
In March 2017: Dr. Wolff launched Alpecin Sport Caffeine Shampoo CTX in Hong Kong. New Alpecin Sport Caffeine Shampoo energises "tired" hair roots. Dr. Wolff Research has been studying the effect of caffeine on hair for 15 years. The result is effective hair care products which prevent hair loss. The new Sport Caffeine Shampoo contains Caffeine and Taurine to ensure effective prevention
Route of Administrations Covered:
• Medicine Product
• Shampoos and Conditioners
Drug Types Covered:
• Potassium Channel Openers
Disease Types Covered:
• Alopecia Areata
• Alopecia Totalis
• Alopecia Universalis
• Androgenetic Alopecia
• Cicatricial Alopecia
• Traction Alopecia
Treatment Types Covered:
• Topical Minoxidil
• Anthralin Cream Or Ointment
• Topical Corticosteroids
• Topical Immunotherapy
• Oral Corticosteroids
• Alpha Reductase Inhibitors
Gender Types Covered:
Distribution Channels Covered:
• Retail Pharmacies
• Online Pharmacies
Sales Channels Covered:
• OTC (Over-the-Counter)
End Users Covered:
• Dermatology Clinics
• Homecare Setting
• North America
o Rest of Europe
• Asia Pacific
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2020, 2021, 2022, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 Executive Summary
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
3 Market Trend Analysis
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Alopecia Market, By Type
5.2 Medicine Product
5.3 Shampoos and Conditioners
6 Global Alopecia Market, By Route of Administration
7 Global Alopecia Market, By Drug Type
7.3 Potassium Channel Openers
8 Global Alopecia Market, By Disease Type
8.2 Alopecia Areata
8.3 Alopecia Totalis
8.4 Alopecia Universalis
8.5 Androgenetic Alopecia
8.6 Cicatricial Alopecia
8.7 Traction Alopecia
9 Global Alopecia Market, By Treatment Type
9.2 Topical Minoxidil
9.3 Anthralin Cream Or Ointment
9.4 Topical Corticosteroids
9.5 Topical Immunotherapy
9.6 Oral Corticosteroids
9.7 Alpha Reductase Inhibitors
10 Global Alopecia Market, By Gender
11 Global Alopecia Market, By Distribution Channel
11.3 Retail Pharmacies
11.4 Online Pharmacies
12 Global Alopecia Market, By Sales Channel
12.3 OTC (Over-the-Counter)
13 Global Alopecia Market, By End User
13.2 Dermatology Clinics
13.3 Homecare Setting
14 Global Alopecia Market, By Geography
14.2 North America
14.3.6 Rest of Europe
14.4 Asia Pacific
14.4.5 New Zealand
14.4.6 South Korea
14.4.7 Rest of Asia Pacific
14.5 South America
14.5.4 Rest of South America
14.6 Middle East & Africa
14.6.1 Saudi Arabia
14.6.4 South Africa
14.6.5 Rest of Middle East & Africa
15 Key Developments
15.1 Agreements, Partnerships, Collaborations and Joint Ventures
15.2 Acquisitions & Mergers
15.3 New Product Launch
15.5 Other Key Strategies
16 Company Profiling
16.2 Dr. Reddy’s Laboratories Ltd
16.3 Merck & Co.
16.6 Ranbaxy Laboratories Ltd
16.7 Kirkland Signature
16.8 Lexington International LLC
16.10 Alpecin - Dr. Kurt Wolff GmbH & Co
16.11 Johnson and Johnson
16.12 GlaxoSmithKline PLC
16.13 Sun Pharmaceutical Industries Ltd
List of Tables
1 Global Alopecia Market Outlook, By Region (2020-2028) (US $MN)
2 Global Alopecia Market Outlook, By Type (2020-2028) (US $MN)
3 Global Alopecia Market Outlook, By Medicine Product (2020-2028) (US $MN)
4 Global Alopecia Market Outlook, By Shampoos and Conditioners (2020-2028) (US $MN)
5 Global Alopecia Market Outlook, By Route of Administration (2020-2028) (US $MN)
6 Global Alopecia Market Outlook, By Oral (2020-2028) (US $MN)
7 Global Alopecia Market Outlook, By Topical (2020-2028) (US $MN)
8 Global Alopecia Market Outlook, By Injectable (2020-2028) (US $MN)
9 Global Alopecia Market Outlook, By Drug Type (2020-2028) (US $MN)
10 Global Alopecia Market Outlook, By Minoxidil (2020-2028) (US $MN)
11 Global Alopecia Market Outlook, By Potassium Channel Openers (2020-2028) (US $MN)
12 Global Alopecia Market Outlook, By Finasteride (2020-2028) (US $MN)
13 Global Alopecia Market Outlook, By Disease Type (2020-2028) (US $MN)
14 Global Alopecia Market Outlook, By Alopecia Areata (2020-2028) (US $MN)
15 Global Alopecia Market Outlook, By Alopecia Totalis (2020-2028) (US $MN)
16 Global Alopecia Market Outlook, By Alopecia Universalis (2020-2028) (US $MN)
17 Global Alopecia Market Outlook, By Androgenetic Alopecia (2020-2028) (US $MN)
18 Global Alopecia Market Outlook, By Cicatricial Alopecia (2020-2028) (US $MN)
19 Global Alopecia Market Outlook, By Traction Alopecia (2020-2028) (US $MN)
20 Global Alopecia Market Outlook, By Treatment Type (2020-2028) (US $MN)
21 Global Alopecia Market Outlook, By Topical Minoxidil (2020-2028) (US $MN)
22 Global Alopecia Market Outlook, By Anthralin Cream Or Ointment (2020-2028) (US $MN)
23 Global Alopecia Market Outlook, By Topical Corticosteroids (2020-2028) (US $MN)
24 Global Alopecia Market Outlook, By Topical Immunotherapy (2020-2028) (US $MN)
25 Global Alopecia Market Outlook, By Oral Corticosteroids (2020-2028) (US $MN)
26 Global Alopecia Market Outlook, By Alpha Reductase Inhibitors (2020-2028) (US $MN)
27 Global Alopecia Market Outlook, By Immunosuppressant (2020-2028) (US $MN)
28 Global Alopecia Market Outlook, By Gender (2020-2028) (US $MN)
29 Global Alopecia Market Outlook, By Malem(2020-2028) (US $MN)
30 Global Alopecia Market Outlook, By Female (2020-2028) (US $MN)
31 Global Alopecia Market Outlook, By Distribution Channel (2020-2028) (US $MN)
32 Global Alopecia Market Outlook, By Hospitals (2020-2028) (US $MN)
33 Global Alopecia Market Outlook, By Retail Pharmacies (2020-2028) (US $MN)
34 Global Alopecia Market Outlook, By Online Pharmacies (2020-2028) (US $MN)
35 Global Alopecia Market Outlook, By Sales Channel (2020-2028) (US $MN)
36 Global Alopecia Market Outlook, By Prescriptions (2020-2028) (US $MN)
37 Global Alopecia Market Outlook, By OTC (Over-the-Counter) (2020-2028) (US $MN)
38 Global Alopecia Market Outlook, By End User (2020-2028) (US $MN)
39 Global Alopecia Market Outlook, By Dermatology Clinics (2020-2028) (US $MN)
40 Global Alopecia Market Outlook, By Homecare Settingn(2020-2028) (US $MN)
Note- Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: email@example.com or phone: +1-301-202-5929
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at firstname.lastname@example.org or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
Select License Type
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.